GMO Global Equity Allocation
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | World Stock | | Fund Family: | GMO | | Net Assets: | 322.61M | | Year-to-Date Return: | -13.20% | | Yield: | 4.61% | | Morningstar Rating: |  | | Fund Inception Date: | 26-Nov-96 |
|
Ben Inker
Lead Manager since
31-Dec-96 | | | Inker is the chief investment officer of quantitative developed equities and director of asset allocation at GMO, which he joined in 1992. Inker holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $10,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks total return. The fund invests in various underlying GMO mutual funds, rather than investing directly in individual securities. It invests primarily in a combination of domestic and foreign equity mutual funds. The fund may also invest in short-term fixed-income securities and high-quality money-markets. |
| Last Dividend
(28-Dec-07):
| 0.49 | | Last Cap Gain
(8-Jul-08):
| 0.82 | | Annual Holdings Turnover
| 30.00% | | Average for Category:
| 61.53% |
|
| Expense | GMGEX | Category
Avg | | Total Expense Ratio: | 0.00%
| 1.56% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.27% | | Max Deferred Sales Load: | 0.00%
| 2.63% | | 3 Yr Expense Projection*: |
$235 | $695 | | 5 Yr Expense Projection*: |
$399 | $1,090 | | 10 Yr Expense Projection*: |
$877 | $2,150 |
|
|
1.49% Nasdaq 
0.27%
Profile
